Literature DB >> 16397778

An unusual patient with kidney stones composed of 1-methyluric acid.

Phillip M Davies1, Lynette D Fairbanks, Krzysztof Safranow, Michael R Bending, H Anne Simmonds.   

Abstract

An unusual case with kidney stones composed mainly of 1-methyluric acid is described. The patient, a Caucasian male of Celtic descent, reportedly drank at least eight cups of coffee per day and had a long history of rheumatoid arthritis, gouty attacks and renal colics--the latter attributed to nephrocalcinosis and analgesic nephropathy. He was treated with allopurinol. At 54 years, a bilateral nephrolithotomy was performed. Stone samples were analysed by thermogravimetry and infrared spectroscopy and reported to be 12-25% calcium oxalate, the remainder being organic uric acid-like material. Analysis of the extracts by HPLC confirmed that the organic material contained 67% of 1-methyluric acid and 33% of uric acid. Possible mechanisms leading to the precipitation of 1-methyluric acid from urine are discussed. We conclude that the high caffeine intake resulted in extremely elevated urinary concentrations of 1-methyluric acid favouring the formation of 1-methyluric acid stones.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397778     DOI: 10.1007/s00240-005-0002-8

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  5 in total

1.  Methylated purines in urinary stones.

Authors:  Krzysztof Safranow; Zygmunt Machoy
Journal:  Clin Chem       Date:  2005-05-26       Impact factor: 8.327

2.  Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.

Authors:  M V Relling; J S Lin; G D Ayers; W E Evans
Journal:  Clin Pharmacol Ther       Date:  1992-12       Impact factor: 6.875

3.  Urinary caffeine metabolites in man. Age-dependent changes and pattern in various clinical situations.

Authors:  D Ullrich; D Compagnone; B Münch; A Brandes; H Hille; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Demonstration of a combined deficiency of xanthine oxidase and aldehyde oxidase in xanthinuric patients not forming oxipurinol.

Authors:  S Reiter; H A Simmonds; N Zöllner; S L Braun; M Knedel
Journal:  Clin Chim Acta       Date:  1990-03-15       Impact factor: 3.786

5.  The conversion of 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) into 4,6-dihroxypyrazolo[3,4-d]pyrimidine (Oxipurinol) in vivo in the absence of xanthine-oxen oxidoreductase.

Authors:  R A Chalmers; R Parker; H A Simmonds; W Snedden; R W Watts
Journal:  Biochem J       Date:  1969-05       Impact factor: 3.857

  5 in total
  2 in total

1.  1-Methyluric Acid Nephropathy.

Authors:  Jeremy Zaworski; Elise Bouderlique; Dany Anglicheau; Jean-Paul Duong Van Huyen; Viviane Gnemmi; Jean-Baptiste Gibier; Yann Neugebauer; Jean-Philippe Haymann; Dominique Bazin; Vincent Frochot; Michel Daudon; Emmanuel Letavernier
Journal:  Kidney Int Rep       Date:  2020-02-22

2.  Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy.

Authors:  Fanliang Zhang; Ruixue Guo; Wen Cui; Li Wang; Jing Xiao; Jin Shang; Zhanzheng Zhao
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.